Punjab-based manufacturer of cephalosporin active pharmaceutical ingredients (APIs), finished-dosage formulations and empty hard gelatin capsules, exporting to 45+ countries.
Price
Market Cap
Sector
Healthcare
Rank
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 | FY25 | FY26 | FY26 |
|---|---|---|---|---|---|---|---|---|
| LiabilitiesEquity Capital | 22 | 22 | 22 | 22 | 22 | 22 | 22 | 19 |
| Reserves | 1.0k | 1.1k | 1.0k | 1.0k | 1.1k | 934 | 694 | 563 |
| Borrowings | 903 | 860 | 754 | 636 | 629 | 582 | 459 | 0 |
| Other Liabilities | 423 | 443 | 371 | 486 | 476 | 509 | 639 | 39 |
| Total Liabilities | 2.4k | 2.4k | 2.2k | 2.2k | 2.2k | 2.0k | 1.8k | 622 |
| AssetsFixed Assets | 772 | 723 | 662 | 643 | 804 | 633 | 28 | 105 |
| CWIP | 99 | 85 | 78 | 66 | 57 | 57 | 0 | 0 |
| Investments | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 13 |
| Other Assets | 1.5k | 1.6k | 1.4k | 1.5k | 1.3k | 1.4k | 1.8k | 504 |
| Total Assets | 2.4k | 2.4k | 2.2k | 2.2k | 2.2k | 2.0k | 1.8k | 622 |
| Line item | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|---|---|
| ActivitiesCash from Operating | 239 | 285 | 21 | 95 | 134 | 225 | 169 | -349 |
| Cash from Investing | -26 | -33 | -29 | 17 | 52 | -17 | -42 | 1.2k |
| Cash from Financing | -201 | -252 | 11 | -119 | -186 | -205 | -128 | -767 |
| SummaryCapital Expenditure | — | — | — | — | — | — | — | — |
| Free Cash Flow | 204 | 249 | -10 | 110 | 183 | 195 | 126 | -341 |
| FCF Margin | — | — | — | — | — | — | — | — |
For capital-heavy businesses (telecom, power, heavy manufacturing) reported profit ignores the cash needed just to stand still. We'd systematically overvalue it, so we don't show a number.
NECLIFE · CAPITAL_INTENSIVE
Guides on how to read this kind of business and the numbers that matter.